Appendix 4G and Corporate Governance Statement 29 August 2017 by Justine Bednorz Appendix 4G and Corporate Governance Statement 2017
Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial 11 April 2017 by Justine Bednorz Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial
Biotron Compounds Demonstrate Activity Against Zika Virus 29 November 201623 May 2016 by Justine Bednorz Biotron Compounds Demonstrate Activity Against Zika Virus
Data Indicates BIT225 May Have a Broader Role in Limiting HIV-1 Infection 18 February 2016 by Justine Bednorz Data Indicates BIT225 May Have a Broader Role in Limiting HIV-1 Infection
Biotron Anti-Viral Compounds to be Tested in USA for Activity Against Zika Virus 17 February 201616 February 2016 by Justine Bednorz Biotron Anti-Viral Compounds to be Tested in USA for Activity Against Zika Virus
New Issue Announcement – Appendix 3B 17 February 201615 January 2016 by Justine Bednorz New Issue Announcement – Appendix 3B
Justine Bednorz